Under the coordination of KU Leuven, the consortium of partners from diverse disciplines, including clinical experts, medical practitioners, data scientists, and health economists, will be working on pioneering personalised therapies for brain cancer patients.

GLIOMATCH 3rd consortium meeting takes place in Düsseldorf, Germany
On World Cancer Day 2025, the GLIOMATCH project participated in the EU project showcase hosted by HaDEA, highlighting the role of EU-funded research in advancing cancer care. We have seized this opportunity to map the EU Cancer Mission project landscape.